United States: Market data & legal analysis of the nicotine sector

Haypp backs EU tax directive amid strong growth in nicotine pouch sales in H1 2025

Written by Antonia Di Lorenzo | 8th August 2025

Haypp Group, an e-commerce player specialising in nicotine pouches and snus, closed the first half of the year with growing performance driven by the nicotine pouch segment ...

JTI posts heated tobacco gains in first half of 2025, Ploom Aura set to expand abroad

Written by Antonia Di Lorenzo | 31st July 2025

Japan Tobacco International reported a solid performance in the first half of 2025, boosted by the ongoing growth of its heated tobacco segment as well as the contribution of Vector Group, acquired last year ...

Velo Plus powers BAT’s modern oral growth despite dip in overall revenue

Written by Antonia Di Lorenzo | 31st July 2025

British American Tobacco reported a slight decrease in its revenue for the first half of 2025, offset by strong growth in the modern oral segment. Velo Plus contributed to growth momentum, particularly in the US...

Altria’s oral tobacco growth softens impact of broader declines in H1 2025

Written by Antonia Di Lorenzo | 30th July 2025

Altria reported a mixed first half of 2025, with overall declines tempered by the strong performance of its oral tobacco products segment – a substantial driver of growth in the second quarter ...

Legal challenges keep US OSH alive while public health experts debate what’s next

Written by Freddie Dawson | 25th July 2025

Talk of the US Office on Smoking and Health’s demise may have been premature, as its employee dismissals have been held up by lawsuits. But what would a post-OSH world look like? ...

Accelerated growth in Iqos and Zyn boosts PMI’s performance in Q2 2025

Written by Antonia Di Lorenzo | 23rd July 2025

Philip Morris International reported a positive performance in the second quarter of the year, driven by a reacceleration of its heated tobacco device, Iqos, and the US offtake growth of its nicotine pouch brand, Zyn...

Forging ahead: technological innovation in reduced-risk products advancing fast

Written by TobaccoIntelligence | 18th July 2025

Unlike filter cigarettes, which basically remained unchanged since they first entered the market in 1934, reduced-risk products have become a realm of innovation since their inception ...

Smart quitting: new inhaler and heating technologies may aid smoking cessation

Written by TobaccoIntelligence | 16th July 2025

The effectiveness of the arsenal of nicotine replacement therapy products available to help smokers quit remains disappointing, but new inhaler technology could deliver better results ...

An overview of enforcement actions: a new TobaccoIntelligence tracker

Written by Freddie Dawson | 15th July 2025

TobaccoIntelligence is introducing a new enforcement tracker that will collate online accounts of regulator action on illicit e-cigarettes and other alternative nicotine products ...

What could happen to the market as Trump spares China in latest tariff battle

Written by Antonia Di Lorenzo | 15th July 2025

China’s exclusion from the new measures, slated to take effect from 1st August, should not be interpreted as a détente, but rather as a tactical choice ...

Advances in age-verification and age-gating technologies could save the day

Written by TobaccoIntelligence | 11th July 2025

Could age-verification and age-gating technologies help get the balance right between flavoured alternative nicotine products as smoking-cessation aids for adults and keeping them away from under-age users? ...

US Supreme Court sides with retailers on their being affected by FDA denial orders

Written by Freddie Dawson | 9th July 2025

The US Supreme Court has again turned to the issue of proper venue for lawsuits, which has been brought to a head by companies challenging US Food and Drug Administration (FDA) decisions on product authorisations...

Trump’s second term so far: pouch use during hearings and government cuts

Written by Freddie Dawson | 3rd July 2025

The first six months of the current administration under US president Donald Trump can be defined by its use of executive orders and imposition of tariffs on goods imported into the US ...

PMI and Swedish Match push for Zyn pouches to get US FDA MRTP status

Written by Freddie Dawson | 24th June 2025

Philip Morris International (PMI)’s modified risk tobacco product (MRTP) submission status for Zyn nicotine pouches has raised a few interesting comparisons with existing reduced-risk products ...

US FDA debuts AI tool ahead of time but early users encounter teething problems

Written by TobaccoIntelligence | 19th June 2025

With great fanfare, the US Food and Drug Administration has announced the rollout of its new artificial intelligence scientific review assistant, Elsa. But questions have been raised about the tool’s potential ...

Another reduced-risk advocacy group closes, leaving space for misinformation

Written by Freddie Dawson | 17th June 2025

Recently, three harm-reduction advocacy organisations have stopped operating, and though they gave different reasons for closing, they have more in common than the explanations might suggest ...

How will the populist pushback in recent elections impact nicotine alternatives?

Written by Freddie Dawson | 16th June 2025

Last November, the feeling was that the election of US president Donald Trump indicated a general shift to the right in global politics, but the results did not quite pan out that way ...

Ispire joint venture files first-ever US FDA PMTA for age-gating chip in ENDS devices

Written by Antonia Di Lorenzo | 2nd June 2025

Ike Tech, co-founded by Ispire, filed the first-ever premarket tobacco product application (PMTA) with the US Food and Drug Administration (FDA) for a system that requires continuous, real-time ID verification to access ENDS devices ...

Spotlight on Big Tobacco’s smoke-free shift: nicotine pouches with potential

Written by TobaccoIntelligence | 29th May 2025

The fourth and final part of our series looks at the impressive growth trajectory of nicotine pouches, the power of brand‑building and the regulatory risks facing the modern oral nicotine category ...

Spotlight on Big Tobacco’s smoke-free shift: rivals in a PMI-dominated market

Written by TobaccoIntelligence | 26th May 2025

In part three of a four-part series, we see how Philip Morris International’s competitors are working hard to catch up in the heated tobacco market and examine Big Tobacco’s strategies for next-generation products ...

Spotlight on Big Tobacco’s smoke-free shift: betting on the future with vaping

Written by TobaccoIntelligence | 22nd May 2025

In part two of a four-part series, we look at the role vaping plays in tobacco companies’ quest to transform themselves into smoke-free businesses, with one company standing out in the category ...

22nd Century launches partner-branded VLN products and rebrands its own line

Written by Antonia Di Lorenzo | 21st May 2025

US-based 22nd Century Group has secured new opportunities to drive volume across its VLN brand very-low-nicotine cigarette products and is launching two partner-branded products ...

New US surgeon general nominee could bode well for harm-reduction products

Written by Freddie Dawson | 20th May 2025

New US surgeon general nominee Casey Means has not publicly laid out any position on vaping, nicotine or smoking cessation, but some of her public comments suggest she may be amenable to reduced-harm products ...

US-China tariff pause eases pressure on nic alternatives sector, but risks still loom

Written by Freddie Dawson | 15th May 2025

Goods imported from China to the US will see a 115% reduction in tariffs as of 14th May, but the abrupt, temporary change offers no real certainty for long-term business planning ...

US tariffs on Chinese vapes may predict the fate of other reduced-risk products

Written by Freddie Dawson | 14th May 2025

This timeline of tariffs will be updated as further changes are made to the US tariff policy on Chinese imports or as new documents are added to the US Federal Register ...

Is there hope for tobacco harm reduction, despite the WHO’s prohibitionist stance?

Written by TobaccoIntelligence | 14th May 2025

Two decades after the adoption of the World Health Organization Framework Convention on Tobacco Control, public health expert Derek Yach asks: ”Surely we could have done better by now?” ...

US-based think tank on how to reform FDA CTP and streamline PMTA process

Written by Freddie Dawson | 12th May 2025

The Tax Foundation has published a series of potential reforms it believes the US Food and Drug Administration’s Center for Tobacco Products could realistically implement to address the country’s nicotine alternatives industry ...

Turning Point Brands Q1 2025 modern oral sales nearly double those of Q4 2024

Written by Freddie Dawson | 12th May 2025

Nicotine pouch sales continue to climb for Turning Point Brands, which reports sales for its modern oral category (which includes pouches and most snuff) reached $22.3m for the first quarter of 2025 ...

Nicotine pouches are more popular in the US, but will that be allowed to continue?

Written by Antonia Di Lorenzo | 8th May 2025

The US nicotine pouch market is currently the world’s largest in value and number of users, and while regulation may impact its growth rates in the future, consumers continue to be attracted to the product...

JTI reports strong Q1 2025 and plans new Ploom launch to boost reduced-risk sales

Written by Antonia Di Lorenzo | 7th May 2025

Japan Tobacco International reported strong performance in the first quarter of 2025 and plans to launch a new Ploom device on 27th May in Japan ...

Altria’s oral tobacco segment stays strong in Q1 amid challenges in other categories

Written by Antonia Di Lorenzo | 30th April 2025

Altria reported some declines in the first quarter of 2025, but its oral tobacco products segment maintained momentum in a competitive marketplace ...

PMI sees strong growth from Zyn and Iqos as it weathers impact of EU flavour ban

Written by Antonia Di Lorenzo | 24th April 2025

Philip Morris International saw a positive start to the year, fuelled by the strong volume momentum of Zyn pouches and Iqos heated tobacco devices, despite the annualisation impact of the EU characterising flavour ban ...

Who really pays for US tariffs on imports of Chinese alternative nicotine products?

Written by Antonia Di Lorenzo | 24th April 2025

The world is wondering what the real implications of US president Donald Trump’s tariffs will be on China, and whether and how the prices of affected products will dramatically increase for US consumers ...

Tense US-EU trade pause: are nicotine alternatives a potential future target?

Written by Antonia Di Lorenzo | 17th April 2025

Trade relations between the US and Europe have been put on a 90-day pause, marked by a tense wait as both sides assess their next moves. Could future developments potentially involve the alternatives sector? ...

Rumours abound of the shutters coming down on US Office on Smoking and Health

Written by Freddie Dawson | 14th April 2025

The US Centers for Disease Control’s Office on Smoking and Health appears to be one of the casualties of job cuts throughout the Department of Health and Human Services ...

Zyn toasts US ‘liberation day’, but Asian vape companies may pay more of a price

Written by Antonia Di Lorenzo | 10th April 2025

After the White House denied the possible suspension of tariffs, the confirmation came yesterday that the president had authorised a 90-day pause for most of the countries receiving them ...

How could a US HHS staff cut by 20,000 affect the nicotine alternatives industry?

Written by Freddie Dawson | 9th April 2025

As the promised axe has fallen on the workforce at the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP), what comes next for the agencies and the industry? ...

Could Trump’s tariffs have a negative impact on public health in the US?

Written by Freddie Dawson | 7th April 2025

US president Donald Trump’s tariffs could actively harm public health – but not in a way that might be expected ...

US health groups and industry analysts scrutinise PMI’s launch of Iqos in Texas

Written by Antonia Di Lorenzo | 1st April 2025

Philip Morris International has officially launched its Iqos heated tobacco device in Texas, marking a significant milestone as the only heated tobacco brand in the country with US FDA marketing authorisation ...

How tariffs on US imported goods could impact the global nicotine industry

Written by Freddie Dawson | 21st March 2025

The imposition of tariffs on goods entering the US could have unintended knock-on effects elsewhere in the world, the most obvious being a general increase to prices, even in places not involved in current tariff...

US youth use of nicotine pouches is up as FDA talks public health campaign success

Written by Freddie Dawson | 20th March 2025

The US Food and Drug Administration (FDA) recently highlighted the success of its Real Cost public health campaign in preventing youth e-cigarette uptake while nicotine pouch use is on the rise ...

Unchanged rate of tobacco product use in US points to need for effective measures

Written by Antonia Di Lorenzo | 13th March 2025

While cigarette smoking in the US has dropped to its lowest level in 60 years, overall tobacco product use among adults has remained unchanged since 2017 ...

Turning Point Brands sees triple-digit growth of nicotine pouch sales in 2024

Written by Freddie Dawson | 10th March 2025

Turning Point Brands has announced it made $11.2m in nicotine pouch sales in the fourth quarter of 2024, with the oral segment (which includes moist snuff) representing over 50% of total net sales last year...

New tariffs on China likely to hit US vape sector, but less so other nic alternatives

Written by Freddie Dawson | 7th March 2025

Further price increases will result from the latest round of tariffs imposed by US president Donald Trump on China – though downstream impact from tariffs on North American trading partners has again been delayed ...

Will policy reversals for US federal staff speed up or slow down FDA efficiency?

Written by Freddie Dawson | 28th February 2025

US HSS decision-makers have been shuttling staff between employment and dismissal, much like the Grand Old Duke of York in the nursery rhyme marches troops up and down a hill ...

US free-speech challenges may reshape marketing rules for nicotine alternatives

Written by TobaccoIntelligence | 18th February 2025

Packaging of US nicotine alternatives could face a major shake-up, thanks to First Amendment challenges against restrictions on what companies can say and do ...

BAT’s heated tobacco sales decline, but offset by strong growth in modern oral

Written by Antonia Di Lorenzo | 14th February 2025

British American Tobacco (BAT) reported a drop in its heated tobacco category in 2024, partially offset by significant growth in the modern oral segment – particularly in the US ...

Can the US tobacco sector expect more stability under Trump’s second term?

Written by Freddie Dawson | 13th February 2025

Predictions on what president Donald Trump will do have always been difficult. But some indicators point to a second go-around of the Trump administration providing a degree more stability and predictability ...

Study that fails to link youth vaping with future smoking brings up research issues

Written by Barnaby Page | 13th February 2025

New research “fails to show that youth vaping causes future smoking”, announces the University of Massachusetts Amherst. Should harm-reduction advocates reach for the champagne? ...

PMI’s growth in 2024 powered by Zyn and Iqos as its smoke-free user base expands

Written by Antonia Di Lorenzo | 6th February 2025

Philip Morris International (PMI) achieved positive results in 2024, driven by the expansion of its nicotine pouch brand Zyn as 2023’s demand acceleration continued alongside Iqos growth momentum ...

LATEST ALERTS

Written by Antonia Di Lorenzo | 8th August 2025

Written by Antonia Di Lorenzo | 31st July 2025

Written by Antonia Di Lorenzo | 31st July 2025

Written by Antonia Di Lorenzo | 30th July 2025

Written by Freddie Dawson | 25th July 2025

Written by Antonia Di Lorenzo | 23rd July 2025

Written by TobaccoIntelligence | 18th July 2025

Written by TobaccoIntelligence | 16th July 2025

Written by Freddie Dawson | 15th July 2025

Written by Antonia Di Lorenzo | 15th July 2025

Written by TobaccoIntelligence | 11th July 2025

Written by Freddie Dawson | 9th July 2025

Written by Freddie Dawson | 3rd July 2025

Written by Freddie Dawson | 24th June 2025

Written by TobaccoIntelligence | 19th June 2025

Written by Freddie Dawson | 17th June 2025

Written by Freddie Dawson | 16th June 2025

Written by Antonia Di Lorenzo | 2nd June 2025

Written by TobaccoIntelligence | 29th May 2025

Written by TobaccoIntelligence | 26th May 2025

Written by TobaccoIntelligence | 22nd May 2025

Written by Antonia Di Lorenzo | 21st May 2025

Written by Freddie Dawson | 20th May 2025

Written by Freddie Dawson | 15th May 2025

Written by Freddie Dawson | 14th May 2025

Written by TobaccoIntelligence | 14th May 2025

Written by Freddie Dawson | 12th May 2025

Written by Freddie Dawson | 12th May 2025

Written by Antonia Di Lorenzo | 8th May 2025

Written by Antonia Di Lorenzo | 7th May 2025

Written by Antonia Di Lorenzo | 30th April 2025

Written by Antonia Di Lorenzo | 24th April 2025

Written by Antonia Di Lorenzo | 24th April 2025

Written by Antonia Di Lorenzo | 17th April 2025

Written by Freddie Dawson | 14th April 2025

Written by Antonia Di Lorenzo | 10th April 2025

Written by Freddie Dawson | 9th April 2025

Written by Freddie Dawson | 7th April 2025

Written by Antonia Di Lorenzo | 1st April 2025

Written by Freddie Dawson | 21st March 2025

Written by Freddie Dawson | 20th March 2025

Written by Antonia Di Lorenzo | 13th March 2025

Written by Freddie Dawson | 10th March 2025

Written by Freddie Dawson | 7th March 2025

Written by Freddie Dawson | 28th February 2025

Written by TobaccoIntelligence | 18th February 2025

Written by Antonia Di Lorenzo | 14th February 2025

Written by Freddie Dawson | 13th February 2025

Written by Barnaby Page | 13th February 2025

Written by Antonia Di Lorenzo | 6th February 2025

Sign up to our newsletter

Curious to see TobaccoIntelligence in action?